THURSDAY, Dec. 29, 2022 (HealthDay News) — The U.S. Food and Drug Administration’s approval process for the controversial Alzheimer’s drug Aduhelm was “rife with irregularities,” despite lingering doubts about the power of the pricey medication to slow the disease down, a Congressional report released Thursday claims. Actions the agency tookContinue Reading

FRIDAY, Dec. 30, 2022 (HealthDay News) — Most working-age Americans get health insurance through their employer, but even they are finding it tougher to afford medical care these days, a new study shows. Researchers found that over the past 20 years, a growing number of Americans with job-based health insuranceContinue Reading